Skip to main content
Clinical Trials/CTRI/2020/10/028381
CTRI/2020/10/028381
Not yet recruiting
Phase 1

A Randomized Clinical study to evaluate the efficacy of Bibhitakadi Ghrita Tarpana and Ayastha Triphala with Ghrita as oral intake in the management of Timira w. s. r. to Presbyopia

ational Institute of Ayurveda Jaipur0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: H524- Presbyopia
Sponsor
ational Institute of Ayurveda Jaipur
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurveda Jaipur

Eligibility Criteria

Inclusion Criteria

  • i) Patients willing to participate in this trial through written informed consent
  • ii) Patients who are 35 years of age and from either sex
  • ii) Patients having specific symptoms of prathama and dwitiya patalagata timira.
  • iii) Early to moderate presbyope determined by screening monocular best\-corrected distant visual acuity (VA)

Exclusion Criteria

  • i) Patients with active ocular infection at visit 1 (bacterial, viral or fungal), positive history of an ocular herpetic infection, preauricular lymphadenopathy, or ongoing, active ocular inflammation (eg, moderate to severe blepharitis, allergic conjunctivitis, peripheral ulcerative keratitis, scleritis, uveitis), moderate to severe dry eye in either eye.
  • ii) Patients with clinically significant abnormal lens findings (eg cataract) including early lens changes and/or any evidence of media opacity in either eye
  • iii) Patients having intraocular pressure (IOP) that is less than 5 millimeters of mercury (mmHg) or greater than 22 mmHg in either eye documented at visit 1, or have a prior diagnosis of ocular hypertension or glaucoma or currently being treated with any type of topical IOP lowering (glaucoma) medication at visit 1\.
  • iv) Patients who have abnormal findings on dilated fundus exam in either eye on visit 1 or a known history of retinal detachment or clinically significant retinal disease in either eye.

Outcomes

Primary Outcomes

Not specified

Similar Trials